Tag: Pancreas
Search News
Research identifies new way to halt pancreatic cancer invasion by targeting healthy cells
10th November 2022
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a new channel of communication through which non-cancerous cells drive the invasion of cancer cells in pancreatic cancer. By blocking a particular signalling molecule within this pathway, called Fibroblast Growth Factor Receptor 1, the team was able to reduce invasion of pancreatic cancer cells in the laboratory.
Read more
Celebrating a New Milestone at the PCRF Tissue Bank
29th September 2022
Recently, the PCRF Tissue Bank registered its 1,000th tissue donor, reaching a new milestone. We spoke with Amina Saad, who is responsible for over 660 donor registrations, including the Tissue Bank’s 1,000th registration, about her role as a Tissue Collection Officer within the Tissue Bank team.
Read more
PCRF’s national pancreas tissue bank extends access to precious pancreas samples
26th August 2022
The world’s first national pancreas tissue bank has recently opened its stores to UK-based researchers to access high-quality pancreas samples that will facilitate vital research into improving the diagnosis and treatment of pancreatic cancer.
Read more
BCI researcher receives new Pancreatic Cancer UK Fellowship
20th July 2022
Congratulations to Dr Audrey Lumeau, Postdoctoral Researcher at Barts Cancer Institute, Queen Mary University of London, who has received a Career Foundation Fellowship from the charity Pancreatic Cancer UK to investigate chromosomal instability in pancreatic cancer and its role in therapy resistance.
Read more
Study suggests simple blood test could help to monitor pancreatic cancer patients
28th April 2022
Researchers from Barts Cancer Institute at Queen Mary University of London have found it is possible to identify and track genetic variations in the tumours of patients with pancreatic cancer using a simple blood test.
Read more
Targeting healthy cells changes invasive behaviour of pancreatic cancer
25th January 2022
Researchers from Barts Cancer Institute at Queen Mary University of London, led by Dr Angus Cameron, have found a way to modulate the invasive behaviour of pancreatic cancer by targeting a non-cancerous cell type found within pancreatic tumours. The findings, published in Cell Reports, provide valuable insights into the biology of pancreatic cancer progression, and could help to drive improvements in cancer treatment.
Read more